{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:38:52Z","timestamp":1783024732806,"version":"3.54.6"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP19K08330, 26221305, JP19H05650, JP20H03464, JP19H04800, JP20K21537, JP22H05189"],"award-info":[{"award-number":["JP19K08330, 26221305, JP19H05650, JP20H03464, JP19H04800, JP20K21537, JP22H05189"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18gm1210003, JP20cm0106372, JP21gm6310024, JP20ek0410082, JP223fa627003"],"award-info":[{"award-number":["JP18gm1210003, JP20cm0106372, JP21gm6310024, JP20ek0410082, JP223fa627003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Kawasaki disease (KD) is an acute systemic vasculitis that predominantly afflicts children. KD development is known to be associated with an aberrant immune response and abnormal platelet activation, however its etiology is still largely unknown. Myosin light chain 9 (Myl9) is known to regulate cellular contractility of both non-muscle and smooth muscle cells, and can be released from platelets, whereas any relations of Myl9 expression to KD vasculitis have not been examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Plasma Myl9 concentrations in KD patients and children with febrile illness were measured and associated with KD clinical course and prognosis. Myl9 release from platelets in KD patients was also evaluated in vitro. Myl9 expression was determined in coronary arteries from Lactobacillus casei cell wall extract (LCWE)-injected mice that develop experimental KD vasculitis, as well as in cardiac tissues obtained at autopsy from KD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and discussion<\/jats:title><jats:p>Plasma Myl9 levels were significantly higher in KD patients during the acute phase compared with healthy controls or patients with other febrile illnesses, declined following IVIG therapy in IVIG-responders but not in non-responders. In vitro, platelets from KD patients released Myl9 independently of thrombin stimulation. In the LCWE-injected mice, Myl9 was detected in cardiac tissue at an early stage before inflammatory cell infiltration was observed. In tissues obtained at autopsy from KD patients, the highest Myl9 expression was observed in thrombi during the acute phase and in the intima and adventitia of coronary arteries during the chronic phase. Thus, our studies show that Myl9 expression is significantly increased during KD vasculitis and that Myl9 levels may be a useful biomarker to estimate inflammation and IVIG responsiveness to KD.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2022.1036672","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:44:30Z","timestamp":1673034270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased Myosin light chain 9 expression during Kawasaki disease vasculitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Hironobu","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko Y.","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichita","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Suganuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Ikehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Ebata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kurashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaro","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Noval Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Arditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Zuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(04)16814-1","article-title":"Kawasaki Syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American heart association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/nejm198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1586\/1744666x.2015.1044980","article-title":"The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease","volume":"11","author":"Burns","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac046","article-title":"Intravenous immunoglobulin induces IgG internalization by tolerogenic myeloid dendritic cells that secrete IL-10 and expand fc-specific regulatory T cells","volume":"208","author":"Hsieh","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.08.006","article-title":"Inflammatory cytokine profiles during cyclosporin treatment for immunoglobulin-resistant Kawasaki disease","volume":"60","author":"Hamada","year":"2012","journal-title":"Cytokine"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/art.37815","article-title":"Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1\/Th2 cytokine profiles in patients with Kawasaki disease","volume":"65","author":"Wang","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1038\/s41467-022-30357-w","article-title":"An artificial intelligence-guided signature reveals the shared host immune response in MIS-c and Kawasaki disease","volume":"13","author":"Ghosh","year":"2022","journal-title":"Nat Commun"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.11.3.405","article-title":"Kawasaki Syndrome","volume":"11","author":"Rowley","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng.2007.59","article-title":"ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms","volume":"40","author":"Onouchi","year":"2008","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/tpj.2011.45","article-title":"ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease","volume":"13","author":"Onouchi","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32003-8","article-title":"Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/imr.12559","article-title":"Crucial role for CD69 in allergic inflammatory responses: CD69-Myl9 system in the pathogenesis of airway inflammation","volume":"278","author":"Kimura","year":"2017","journal-title":"Immunol Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-019-00734-7","article-title":"A new therapeutic target: the CD69-Myl9 system in immune responses","volume":"41","author":"Kimura","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900646","article-title":"CD69 controls the pathogenesis of allergic airway inflammation","volume":"183","author":"Miki-Hosokawa","year":"2009","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"eaaf9154","DOI":"10.1126\/sciimmunol.aaf9154","article-title":"Myosin light chains 9 and 12 are functional ligands for CD69 that regulate airway inflammation","volume":"1","author":"Hayashizaki","year":"2016","journal-title":"Sci Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594297","article-title":"Myosin light chain 9\/12 regulates the pathogenesis of inflammatory bowel disease","volume":"11","author":"Yokoyama","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.immuni.2019.05.021","article-title":"Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation","volume":"51","author":"Noval Rivas","year":"2019","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200x.2003.01810.x","article-title":"Spontaneous platelet aggregation in Kawasaki disease using the particle counting method","volume":"45","author":"Taki","year":"2003","journal-title":"Pediatr Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-1037","article-title":"Platelet activation dynamics evaluated using platelet-derived microparticles in Kawasaki disease","volume":"78","author":"Yahata","year":"2014","journal-title":"Circ J"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2017.32.7.1147","article-title":"The usefulness of platelet-derived microparticle as biomarker of antiplatelet therapy in Kawasaki disease","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"17641","DOI":"10.1038\/s41598-019-54113-1","article-title":"Changes in and significance of platelet function and parameters in Kawasaki disease","volume":"9","author":"Zheng","year":"2019","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.54","article-title":"Kawasaki Disease: insights into pathogenesis and approaches to treatment","volume":"11","author":"Shulman","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.echo.2016.03.017","article-title":"A new z score curve of the coronary arterial internal diameter using the lambda-Mu-Sigma method in a pediatric population","volume":"29","author":"Kobayashi","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.111.072769","article-title":"Interleukin-1\u03b2 is crucial for the induction of coronary artery inflammation in a mouse model of Kawasaki disease","volume":"125","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1538\/expanim.19-0124","article-title":"A novel mouse model of coronary stenosis mimicking Kawasaki disease induced by lactobacillus casei cell wall extract","volume":"69","author":"Suganuma","year":"2020","journal-title":"Exp Anim"},{"key":"B30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2144\/000112517","article-title":"ImageJ for microscopy","volume":"43","author":"Collins","year":"2007","journal-title":"Biotechniques"},{"key":"B31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s1074-7613(03)00177-8","article-title":"Platelet-mediated modulation of adaptive immunity","volume":"19","author":"Elzey","year":"2003","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/inf.0000000000002563","article-title":"Platelet count variation and risk for coronary artery abnormalities in Kawasaki disease","volume":"39","author":"Ae","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2009.04073.x","article-title":"Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease","volume":"160","author":"Ikeda","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/ped.12120","article-title":"Utility of whole-blood aggregometry for evaluating anti-platelet therapy for Kawasaki disease","volume":"55","author":"Suzuki","year":"2013","journal-title":"Pediatr Int"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2220","article-title":"A genome-wide association study identifies three new risk loci for Kawasaki disease","volume":"44","author":"Onouchi","year":"2012","journal-title":"Nat Genet"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1600388","article-title":"Inositol-triphosphate 3-kinase c mediates inflammasome activation and treatment response in Kawasaki disease","volume":"197","author":"Alphonse","year":"2016","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.121.319153","article-title":"NLRP3 inflammasome mediates immune-stromal interactions in vasculitis","volume":"129","author":"Porritt","year":"2021","journal-title":"Circ Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2203437119","article-title":"Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity","volume":"119","author":"Iwamura","year":"2022","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(20)30420-3","article-title":"COVID-19 vasculitis and novel vasculitis mimics","volume":"3","author":"McGonagle","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2021.05.007","article-title":"COVID-19 vasculopathy: Mounting evidence for an indirect mechanism of endothelial injury","volume":"191","author":"Nicosia","year":"2021","journal-title":"Am J Pathol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036672\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T19:44:34Z","timestamp":1673034274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1036672\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2022.1036672"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1036672","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"article-number":"1036672"}}